Buscar resultados de ensayos clínicos

Patrocinado por

Severe Dengue - 15 Studies Found

Estado Estudiar
Active, not recruiting Nombre del estudio: Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine
Condición:
  • Dengue Fever
  • Dengue Haemorrhagic Fever

Fecha: 2016-06-29
Completed Nombre del estudio: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2016-07-01
Intervenciones:
  • Biological: CYD Dengue Vaccine (5 dose formulation)

Enrolling by invitation Nombre del estudio: Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2016-10-27
Completed Nombre del estudio: Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2010-12-03
Intervenciones:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 vi
Not yet recruiting Nombre del estudio: Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2016-12-12
Intervenciones:
  • Biological: CYD Dengue Vaccine

Completed Nombre del estudio: Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2010-05-27
Intervenciones:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4

Completed Nombre del estudio: A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2010-02-05
Intervenciones:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 vir
Active, not recruiting Nombre del estudio: Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2015-12-09
Intervenciones:
  • Biological: CYD Dengue Vaccine

Active, not recruiting Nombre del estudio: Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule
Condición:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

Fecha: 2015-12-03
Intervenciones:
  • Biological: CYD Dengue Vaccine (5-dose formulation)

Completed Nombre del estudio: Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus
Condición:
  • Dengue Shock Syndrome
  • Dengue Hemorrhagic Fever

Fecha: 2009-06-11
Intervenciones:
  • Biological: DEN4 Vaccine Candidate

Next >>>